Kangxin Hou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kangxin Hou has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Caixia Wang
State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China
6 shared publications Qiang Xue
State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs
4 shared publicationsJia Liu
State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China
3 shared publicationsXinyao Su
State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China
3 shared publications- Jie Qiu
Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, No. 16, Nanxiaojie, Dongzhimennei, Beijing 100700, P. R. China
2 shared publications Wantong Yu
State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China
2 shared publications
Latest Publications
- 12 May 2026
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 74 (19) , 15182-15194
Identification of Trifolium repens as a New Source of Glycyrrhetinic Acid: Pathway Elucidation and Heterologous Reconstruction in Yeast
Glycyrrhetinic acid (GA) is a pharmacologically important oleanane-type triterpenoid best known from licorice, but its sustainable production is limited by inefficient enzymes. Here, we report the complete GA biosynthetic pathway in Trifolium repens, a legume not previously known to produce GA. Targeted metabolomics confirmed GA accumulation in multiple tissues, highest in roots. Transcriptomic analyses identified key biosynthetic genes, and heterologous reconstruction in yeast verified their catalytic functions. The pathway comprises three β-amyrin synthases, two β-amyrin 11-oxidases (TrCYP88D37/35b), and an 11-oxo-β-amyrin 30-oxidase (TrCYP72A1633). Phylogenetic analyses revealed these CYP450s are conserved in supertribe Fabodae, hinting at the potential for GA or related triterpenoid production in other legumes. Screening seven cytochrome P450 reductases (CPRs), including two from T. repens, identified AiCPR from Azadirachta indica as optimal for TrCYP72A1633, increasing GA titers in yeast to 3.07 mg/L. This study establishes GA biosynthesis in T. repens and provides a basis for sustainable microbial production.
- 12 May 2026
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 74 (19) , 15182-15194
Identification of Trifolium repens as a New Source of Glycyrrhetinic Acid: Pathway Elucidation and Heterologous Reconstruction in Yeast
Glycyrrhetinic acid (GA) is a pharmacologically important oleanane-type triterpenoid best known from licorice, but its sustainable production is limited by inefficient enzymes. Here, we report the complete GA biosynthetic pathway in Trifolium repens, a legume not previously known to produce GA. Targeted metabolomics confirmed GA accumulation in multiple tissues, highest in roots. Transcriptomic analyses identified key biosynthetic genes, and heterologous reconstruction in yeast verified their catalytic functions. The pathway comprises three β-amyrin synthases, two β-amyrin 11-oxidases (TrCYP88D37/35b), and an 11-oxo-β-amyrin 30-oxidase (TrCYP72A1633). Phylogenetic analyses revealed these CYP450s are conserved in supertribe Fabodae, hinting at the potential for GA or related triterpenoid production in other legumes. Screening seven cytochrome P450 reductases (CPRs), including two from T. repens, identified AiCPR from Azadirachta indica as optimal for TrCYP72A1633, increasing GA titers in yeast to 3.07 mg/L. This study establishes GA biosynthesis in T. repens and provides a basis for sustainable microbial production.
- Open Access
- 1 February 2024
- Published by KEAI Publishing in Green Energy & Environment
- Vol. 9 (2) , 403-412
Comprehensive reutilization of herbal waste: Coproduction of magnolol, honokiol, and β-amyrin from Magnolia officinalis residue
- 1 February 2024
- Published by KEAI Publishing in Green Energy & Environment
- Vol. 9 (2) , 403-412
Open AccessComprehensive reutilization of herbal waste: Coproduction of magnolol, honokiol, and β-amyrin from Magnolia officinalis residue
- 24 January 2024
- Published by American Chemical Society (ACS) in ACS Sustainable Chemistry & Engineering
- Vol. 12 (5) , 1960-1972
Efficient Production of Neohesperidin Enabled by Protein Engineering of Rhamnosyltransferase Cm1,2RhaT
- 24 January 2024
- Published by American Chemical Society (ACS) in ACS Sustainable Chemistry & Engineering
- Vol. 12 (5) , 1960-1972
Efficient Production of Neohesperidin Enabled by Protein Engineering of Rhamnosyltransferase Cm1,2RhaT
- 16 February 2023
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 71 (8) , 3766-3776
Production of 11-Oxo-β-Amyrin in Saccharomyces cerevisiae at High Efficiency by Fine-Tuning the Expression Ratio of CYP450:CPR
The production of glycyrrhetinic acid (GA) and 11-oxo-β-amyrin, the major bioactive components in liquorice, was typically inhibited by P450 oxidation in Saccharomyces cerevisiae. This study focused on optimizing CYP88D6 oxidation by balancing its expression with cytochrome P450 oxidoreductase (CPR) for the efficient production of 11-oxo-β-amyrin in yeast. Results indicated that a high CPR:CYP88D6 expression ratio could decrease both 11-oxo-β-amyrin concentration and turnover ratio of β-amyrin to 11-oxo-β-amyrin, whereas a high CYP88D6:CPR expression ratio is beneficial for improving the catalytic activity of CYP88D6 and 11-oxo-β-amyrin production. Under such a scenario, 91.2% of β-amyrin was converted into 11-oxo-β-amyrin in the resulting S. cerevisiae Y321, and 11-oxo-β-amyrin production was further improved to 810.6 mg/L in fed-batch fermentation. Our study provides new insights into the expression of cytochrome P450 and CPR in maximizing the catalytic activity of P450s, which could guide the construction of cell factories in producing natural products.
- 16 February 2023
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 71 (8) , 3766-3776
Production of 11-Oxo-β-Amyrin in Saccharomyces cerevisiae at High Efficiency by Fine-Tuning the Expression Ratio of CYP450:CPR
The production of glycyrrhetinic acid (GA) and 11-oxo-β-amyrin, the major bioactive components in liquorice, was typically inhibited by P450 oxidation in Saccharomyces cerevisiae. This study focused on optimizing CYP88D6 oxidation by balancing its expression with cytochrome P450 oxidoreductase (CPR) for the efficient production of 11-oxo-β-amyrin in yeast. Results indicated that a high CPR:CYP88D6 expression ratio could decrease both 11-oxo-β-amyrin concentration and turnover ratio of β-amyrin to 11-oxo-β-amyrin, whereas a high CYP88D6:CPR expression ratio is beneficial for improving the catalytic activity of CYP88D6 and 11-oxo-β-amyrin production. Under such a scenario, 91.2% of β-amyrin was converted into 11-oxo-β-amyrin in the resulting S. cerevisiae Y321, and 11-oxo-β-amyrin production was further improved to 810.6 mg/L in fed-batch fermentation. Our study provides new insights into the expression of cytochrome P450 and CPR in maximizing the catalytic activity of P450s, which could guide the construction of cell factories in producing natural products.
- 19 September 2022
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 70 (38) , 12055-12064
Boosting the Cannabidiol Production in Engineered Saccharomyces cerevisiae by Harnessing the Vacuolar Transporter BPT1
Cannabidiol (CBD), the main nonpsychoactive cannabinoid in Cannabis sativa, has diverse applications in the pharmacological, food, and cosmetic industries. The long plantation period and the complex chemical structure of cannabidiol pose a great challenge on CBD supply. Here, we achieved de novo biosynthesis of cannabidiol in Saccharomyces cerevisiae. The CBD production was further enhanced by 2.53-fold through pushing the supply of precursors and fusion protein construction. Bile pigment transporter 1 (BPT1) was the most effective transporter for transferring cannabigerolic acid (CBGA) from the cytoplasm to the vacuole, which removed the physical barrier separating CBGA and its catalytic enzyme. The lowest binding energy of the CBGA-BPT1 complex confirmed a strong interaction between BPT1 and CBGA. A CBD yield of 6.92 mg/L was achieved, which was 100-fold higher than the yield generated by the starting strain. This study provides insights into high-level CBD-producing strain construction and lays the foundation for CBD supply.
- 19 September 2022
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 70 (38) , 12055-12064
Boosting the Cannabidiol Production in Engineered Saccharomyces cerevisiae by Harnessing the Vacuolar Transporter BPT1
Cannabidiol (CBD), the main nonpsychoactive cannabinoid in Cannabis sativa, has diverse applications in the pharmacological, food, and cosmetic industries. The long plantation period and the complex chemical structure of cannabidiol pose a great challenge on CBD supply. Here, we achieved de novo biosynthesis of cannabidiol in Saccharomyces cerevisiae. The CBD production was further enhanced by 2.53-fold through pushing the supply of precursors and fusion protein construction. Bile pigment transporter 1 (BPT1) was the most effective transporter for transferring cannabigerolic acid (CBGA) from the cytoplasm to the vacuole, which removed the physical barrier separating CBGA and its catalytic enzyme. The lowest binding energy of the CBGA-BPT1 complex confirmed a strong interaction between BPT1 and CBGA. A CBD yield of 6.92 mg/L was achieved, which was 100-fold higher than the yield generated by the starting strain. This study provides insights into high-level CBD-producing strain construction and lays the foundation for CBD supply.
- 8 March 2022
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 70 (11) , 3467-3476
Metabolic Engineering of Saccharomyces cerevisiae for de Novo Dihydroniloticin Production Using Novel CYP450 from Neem (Azadirachta indica)
Azadirachtin, a limonoid isolated from the neem tree, has attracted considerable interest due to its excellent performance in pest control. Studies have also reported pharmaceutical activities of dihydroniloticin, an intermediate in azadirachtin biosynthesis, but these pharmaceutical activities could not be validated due to the limited supply. In this study, AiCYP71CD2 was first identified as involved in azadirachtin biosynthesis in neem by expressing it in Nicotiana benthamiana and yeast (Saccharomyces cerevisiae). Homology modeling and molecular docking analysis revealed that AiCYP71CD2 may exhibit a higher ability in catalyzing tirucalla-7,24-dien-3β-ol into dihydroniloticin compared with MaCYP71CD2 from Melia azedarach L. G310 was identified as the critical residue responsible for the higher catalytic ability of AiCYP71CD2. Condon-Optimized AiCYP71CD2 greatly improved the catalytic efficiency in yeast. De novo dihydroniloticin production using the novel AiCYP71CD2 was achieved by constructing the S. cerevisiae DI-3 strain, and the titer could reach up to 405 mg/L in a fermentor, which was an alternative source for dihydroniloticin.
- 8 March 2022
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 70 (11) , 3467-3476
Metabolic Engineering of Saccharomyces cerevisiae for de Novo Dihydroniloticin Production Using Novel CYP450 from Neem (Azadirachta indica)
Azadirachtin, a limonoid isolated from the neem tree, has attracted considerable interest due to its excellent performance in pest control. Studies have also reported pharmaceutical activities of dihydroniloticin, an intermediate in azadirachtin biosynthesis, but these pharmaceutical activities could not be validated due to the limited supply. In this study, AiCYP71CD2 was first identified as involved in azadirachtin biosynthesis in neem by expressing it in Nicotiana benthamiana and yeast (Saccharomyces cerevisiae). Homology modeling and molecular docking analysis revealed that AiCYP71CD2 may exhibit a higher ability in catalyzing tirucalla-7,24-dien-3β-ol into dihydroniloticin compared with MaCYP71CD2 from Melia azedarach L. G310 was identified as the critical residue responsible for the higher catalytic ability of AiCYP71CD2. Condon-Optimized AiCYP71CD2 greatly improved the catalytic efficiency in yeast. De novo dihydroniloticin production using the novel AiCYP71CD2 was achieved by constructing the S. cerevisiae DI-3 strain, and the titer could reach up to 405 mg/L in a fermentor, which was an alternative source for dihydroniloticin.